Data Driven Behavior Intervention and Medical Outcome Evaluation of Patients' Comprehensive Monitoring

Sponsor

Peking Union Medical College Hospital (Other)

Overall Status

Not yet recruiting

CT.gov ID

NCT04966754

Collaborator

Peking University (Other), Guangdong Provincial People's Hospital (Other), Guangzhou Huyun Hospital Management Co., Ltd (Other)

1,000

Enrollment

Anticipated Duration (Months)

Study Details

Study Description

Brief Summary

During the study, the resuscitation room, general wards and ICU were installed fixed or mobile acquisition devices in the resuscitation room, the emergency department of Peking Union Medical College Hospital, and the collection platform was set up. Patients with acute diseases (infection, diabetes complications, etc.) caused by metabolic syndrome (obesity, diabetes, etc.) were selected after informed consent. All medical intervention behaviors, relevant medical records and medical outcome records within the collection scope of the device platform were collected prospectively . And regular follow-up, guidance of patients with metabolic syndrome control, while collecting all the lifestyle characteristics of patients, some patients with metabolic cabin research, and observe the relevant medical outcomes. After that, all the collected data were coded, and the influence of all lifestyle and medical behavior interventions on patients' medical outcomes was studied by artificial intelligence method.

Condition or Disease	Intervention/Treatment	Phase
Metabolic Syndrome Metabolic Disturbance Metabolic Complication Infection Obesity Diabetes

Study Design

Study Type:

Observational

Anticipated Enrollment :

1000 participants

Observational Model:

Cohort

Time Perspective:

Prospective

Official Title:

Data Driven Behavior Intervention and Medical Outcome Evaluation of Patients' Comprehensive Monitoring

Anticipated Study Start Date :

Aug 1, 2021

Anticipated Primary Completion Date :

Nov 30, 2023

Anticipated Study Completion Date :

Nov 30, 2023

Outcome Measures

Primary Outcome Measures

Rate of metabolic complications [6 weeks]
Relapse of acute metabolic disease, stability of biochemical metabolic indexes (such as glycosylated hemoglobin, BMI)
Complication control [3 weeks]
The occurrence of metabolic complications, infection and cardiovascular events
Rate of mortality [6 months]
30-day and 90-day mortality. Death due to cardiovascualr complications

Secondary Outcome Measures

Total cost of treatment [3 weeks]
Length of stay, length of stay in ICU, ventilator usage time
Quality of life [6 months]
Dynamic monitoring of quality of life through quality-of-life evaluation chart

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

Diabetes and / or obesity (BMI>=28).
Emergency room / emergency ward / EICU;
Be able to understand and agree the research protocol and sign the informed consent

Exclusion Criteria:

Pregnant women / lactation period;
The estimated survival time was less than 1 year;
Long term follow-up is not guaranteed;
Failure to comply with the protocol or procedure;
The collection of medical behavior data can not complete the de privacy or label after de privacy;
Other researchers think that it is not suitable for inclusion